Caliper Life Sciences Inc., of Hopkinton, Mass., elected Kathryn Tunstall and Edgar Cummins to its board.
Can-Fite Biopharma Ltd., of Petach-Tikvah, Israel, appointed Ashleigh Palmer chief business officer in charge of U.S. corporate development.
Cephalon Inc., of West Chester, Pa., hired Kenneth Fiorelli as vice president of global process development.
Cetek Corp., of Marlborough, Mass., appointed Vincent Gullo vice president of drug discovery.
Chiron Corp., of Emeryville, Calif., appointed Rino Rappuoli chief scientific officer.
CoTherix Inc., of Belmont, Calif., appointed James Pennington chief medical officer.
DeCode Genetics Inc., of Reykjavik, Iceland, appointed Goran Ando to its board.
Diversa Corp., of San Diego, appointed Cheryl Wenzinger to its board.
DOR BioPharma Inc., of Miami, appointed James Kuo and Stuart Sedlack to its board.
Dyax Corp., of Cambridge, Mass., appointed Mary Ann Gray to its board.
EpiTan Ltd., of Melbourne, Australia, hired Perry Robins as a medical advisory consultant.